Benjamin L. Palleiko - 18 May 2023 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
President, CFO, CBO & Sec'y
Signature
/s/ Benjamin L. Palleiko
Issuer symbol
KALV
Transactions as of
18 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 21:33:51 UTC
Previous filing
22 May 2023
Next filing
21 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Employee Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 18 May 2023 Common Stock 40,000 $10.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a 4 year period: 1/48th on June 18, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.